Clinical guidelines don’t recommend valve replacement for patients with severe aortic stenosis (AS) demonstrating normal flow and low gradients. But maybe they should, according to new research published in JACC: Cardiovascular Imaging.

Despite encountering more short-term complications after transcatheter aortic valve replacement (TAVR), women have better long-term survival rates than men, according to a meta-analysis of 47,188 patients. However, they remain at greater risk for stroke.

Published online Oct. 17 in the Journal of the American College of Cardiology, the guidelines offer recommendations on when to use transcatheter aortic valve replacement (TAVR), surgical aortic valve replacement (SAVR) or neither—and when either technique may be appropriate.

The 29th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium kicks off in Denver in less than two weeks. In preparation, Gregg W. Stone, MD, co-director of medical research and education at the Cardiovascular Research Foundation, provided some expected highlights of this year’s session Oct. 16 during a press briefing.

Relatively few patients with chronic kidney disease (CKD) require dialysis after undergoing transcatheter aortic valve replacement (TAVR), according to a new study.

A new study published in the journal Science Signaling suggests fever during pregnancy is directly related to the development of heart defects and facial complications like cleft lip and palate, a phenomenon that might be managed with something as simple as Tylenol.

A medical implant that can expand internally to accommodate a child’s growth could be revolutionizing the field of pediatric surgery, according to a Massachusetts-based research team.

Interventional cardiologist Richard Zelman, MD, has performed about 245 transcatheter aortic valve replacement (TAVR) procedures since it debuted at Cape Cod Hospital two-and-a-half years ago. But never one like he experienced in August.